Business Context and Reporting Period
This Form 8-K is filed by Immudyne, Inc. (noted as Lifemd, Inc. in metadata) on October 11, 2016. The report discloses preliminary financial results for the period ended September 30, 2016, and the release of a new corporate presentation on October 12, 2016.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. It references a press release (Exhibit 99.1) containing preliminary results for the period ended September 30, 2016, but the data itself is not included in the provided text.
Material Changes
The filing does not contain specific data to compare current performance against prior periods. It serves as a notification that preliminary results have been issued.
Guidance, Outlook, and Risks
The company released a new corporate presentation (Exhibit 99.2) on October 12, 2016, which may contain outlook or management commentary. The filing explicitly states that the information in Item 2.02 and Item 7.01 is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not incorporated by reference unless expressly stated.
Investor Verification Checklist
- Verify the specific financial figures in the press release attached as Exhibit 99.1.
- Review the corporate presentation attached as Exhibit 99.2 for updated guidance or strategic shifts.
- Confirm the discrepancy between the metadata company name (Lifemd, Inc.) and the registrant name in the filing (Immudyne, Inc.).
- Note that the financial data in this 8-K is not legally "filed" under Section 18 of the Exchange Act.